HomeIMVT • NASDAQ
add
Immunovant Inc
Previous close
$24.06
Day range
$24.85 - $27.35
Year range
$12.72 - $27.80
Market cap
5.48B USD
Avg Volume
1.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 114.36M | 0.05% |
Net income | -110.64M | 0.44% |
Net profit margin | — | — |
Earnings per share | -0.54 | 29.30% |
EBITDA | -114.26M | -0.05% |
Effective tax rate | -1.42% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 994.52M | 165.43% |
Total assets | 1.05B | 150.01% |
Total liabilities | 66.26M | -3.01% |
Total equity | 986.14M | — |
Shares outstanding | 203.32M | — |
Price to book | 4.96 | — |
Return on assets | -34.97% | — |
Return on capital | -37.97% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -110.64M | 0.44% |
Cash from operations | -92.32M | 8.03% |
Cash from investing | — | — |
Cash from financing | 564.60M | 22,814.08% |
Net change in cash | 472.66M | 581.04% |
Free cash flow | -61.78M | -0.27% |
About
Founded
2018
Website
Employees
362
